Published in Obesity and Diabetes Week, April 17th, 2006
"Our expanded CRADA is an important step in accelerating the level of our research activities and reflects the confidence that we have in the potential of our science and our scientific team," states Harmel S. Rayat, president and CEO of PhytoMedical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.